2-(chloromethyl)-3-methylquinoxaline, 95.0%, 250mg

1,2-Bis(chlorodimethylsilyl)ethane [Protecting Reagent for Primary Amines]>95.0%(GC)25g

round cuvette test NANOCOLOR® Tenside 15, non ionic

Ethyl 2,2-difluoroheptanoate, 95.0%, 5g

1-tert-Butoxycarbonyl-1H-pyrazole-4-boronic acid, 98.0%, 1g

3-(Trifluoromethyl)pyrrolidine-3-carboxylic acid, 95.0%, 100mg

5-(Tert-butyl)-2-hydroxy-3-methylbenzaldehyde, 98%, 500mg

1-[(4-tert-butyl-1,3-thiazol-2-yl)methyl]piperazine, 95.0%, 500mg

Plan phase PLPHi S40x/0.65 infinity corrected IOS objective. Working distance 0.66 mm

2-(Bromomethyl)naphthalene>97.0%(GC)5g

PYRROLO[3,4-C]PYRROLE, OCTAHYDRO-, CIS-, 95.0%, 5g

(R)-4-(Dibenzylamino)-3-fluoro-2-methylbutan-2-ol, 97%, 250mg

1,2,4,5-Tetrafluoro-3-methoxybenzene, 95.0%, 25g